首頁 > 市場調查報告書 > 製藥

疫苗動物用醫藥

市場調查報告書

商品編碼

1738660

全球家禽疫苗市場規模（依產品類型、疾病類型、劑型、應用、地區、範圍和預測）

Global Poultry Vaccines Market Size By Product Type (Modified or Attenuated, Inactivated, Recombinants), By Disease Type, By Dosage Form, By Application, By Geographic Scope And Forecast

出版日期: 2025年05月02日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

家禽疫苗市場規模及預測

2024 年家禽疫苗市場規模價值 21.5 億美元，預計 2032 年將達到 34.2 億美元，2026 年至 2032 年的複合年成長率為 5.95%。

家禽疫苗是保護雞、火雞、鴨和其他家禽免受感染疾病的生物製品。
疫苗旨在增強鳥類的免疫系統，使它們更能免疫力某些疾病，如病毒和細菌。
此外，家禽疫苗可用於預防禽群疾病爆發，改善禽類整體健康狀況，降低死亡率，並提高家禽養殖產量。有效的疫苗接種計畫還能減少疾病透過食用禽類產品從家禽傳播給人類，有助於確保食品安全。

全球家禽疫苗市場動態

關鍵市場促進因素

禽類疾病和生物安全問題日益令人擔憂：新城疫、禽流感和傳染性支氣管炎病毒 (IBV) 持續對全球家禽業構成挑戰，導致禽類死亡、產蛋量下降以及貿易限制造成的經濟損失。疫苗接種對於疾病防治至關重要，從而能夠提高家禽養殖場的生物安全水平。隨著對這些危害及其經濟影響的認知不斷加深，對有效家禽疫苗的需求也日益成長。
禽肉需求成長，禽群規模擴大：禽肉因其價格實惠、健康益處和烹飪多樣性，在世界各地越來越受歡迎。這一趨勢導致家禽養殖場的禽群規模不斷擴大，以滿足生產需求。然而，禽群規模越大，疾病傳播的風險就越高。在人口密集的地區，接種疫苗對於預防傳染病和維護禽群健康至關重要。
關注食品安全和公共衛生：消費者重視食品安全，並擔心透過家禽產品傳播的疾病。家禽疫苗接種計劃透過限制通用感染疾病的傳播來降低這些風險。健康的家禽群能夠穩定地供應安全優質的肉類，而政府為公共衛生和產業生物安全推廣疫苗接種的措施也對此提供了支持。

主要挑戰

疫苗接種失敗與低溫運輸管理：疫苗接種失敗的原因多種多樣，包括接種技術不當、疫苗儲存或運輸不當（低溫運輸中斷）以及接種禽類的免疫反應不足。這些失敗會導致即使嘗試接種疫苗，疾病仍然爆發。解決這些問題並提高疫苗接種效果可能需要確保正確的疫苗接種方法、維護可靠的疫苗儲存和運輸低溫運輸，以及生產更具免疫抗原性的疫苗。
疫苗接種計畫的成本與實施：疫苗接種計畫需要在疫苗、設備和訓練有素的人員方面進行投資。這給家禽養殖戶，尤其是小規模養殖戶帶來了經濟負擔。此外，在大型農場實施高效率的疫苗接種計畫需要周詳的規劃、物流和生物安全預防措施。開發經濟有效的疫苗接種方法、為養殖戶提供培訓和技術援助以及簡化疫苗接種程序，都有助於克服這些挑戰並提高疫苗接種覆蓋率。

主要趨勢：

重組疫苗和載體疫苗的開發：傳統家禽疫苗使用去活化病原體，重組疫苗利用特定基因觸發免疫反應，載體疫苗則利用無害病毒遞送保護性抗原。這些現代方法有望為雞群提供更廣泛的保護，提高安全性並提升疫苗接種的生產效率。
卵內免疫接種及自動化重點：卵內免疫接種是指將疫苗注射到胚胎蛋中，比傳統技術更早保護雞隻，並產生更好的免疫反應。自動化，包括自動化疫苗接種設備和數據系統，旨在簡化流程，最大限度地降低人事費用，並確保所有家禽農場的疫苗接種準確一致。
多重藥物免疫計畫和疫苗接種監測的興起：多重藥物免疫計畫使用多種疫苗來對抗新興疾病並改善雞群健康。借助先進的監測工具，農民可以即時評估疫苗接種覆蓋率、抗體水平和疾病發生情況，從而最佳化疫苗接種策略並加強整體禽類健康管理。

Poultry vaccines are biological products that protect chickens, turkeys, ducks, and other poultry animals from infectious illnesses.
The vaccines are designed to boost the immune system of birds, allowing them to build immunity to specific diseases such as viruses and bacteria.
Furthermore, poultry vaccines are used to prevent disease outbreaks within flocks, improving general bird health, lowering mortality rates, and increasing production in the poultry business. Effective vaccination programs also help to ensure food safety by reducing the spread of diseases from poultry to humans through the consumption of chicken products.

Global Poultry Vaccines Market Dynamics

The key market dynamics that are shaping the poultry vaccines market include:

Key Market Drivers

Rising Concerns About Avian Diseases and Biosecurity: Newcastle disease, Avian Influenza (bird flu), and Infectious Bronchitis Virus (IBV) continue to pose challenges to the worldwide poultry sector, resulting in economic losses due to bird death, lower egg production, and trade restrictions. Vaccination is critical for disease prevention and management, which improves biosecurity on chicken farms. Growing knowledge of these hazards and their economic consequences fuels the demand for effective poultry vaccines.
Increasing Demand for Poultry Meat and Growing Flock Sizes: Poultry meat is becoming more popular worldwide due to its affordability, health benefits, and culinary variety. This trend leads to increased flock sizes on chicken farms to fulfill production demands. However, larger flocks increase the likelihood of disease transmission. Vaccination becomes critical in densely populated areas to avoid epidemics and keep flocks healthy.
Focus on Food Safety and Public Health: Consumers value food safety and are concerned about diseases spread through poultry products. Poultry vaccination programs reduce these hazards by limiting the transmission of zoonotic illnesses, which are transmissible from animals to people. Healthy poultry flocks maintain a steady supply of safe, high-quality meat, which is aided by government initiatives to promote vaccination for public health and industry biosecurity.

Key Challenges:

Vaccination Failures and Cold Chain Management: Vaccination failures occur for a variety of reasons, including ineffective administration techniques, wrong vaccine storage or transportation (breaking the cold chain), or insufficient immunological response in vaccinated birds. Regardless of immunization attempts, these failures result in disease outbreaks. Addressing this difficulty and improving vaccination efficacy can be accomplished by ensuring adequate vaccination practices, maintaining a dependable cold chain for vaccine storage and shipping, and potentially producing stronger immunogenic vaccines.
Cost Considerations and Vaccination Program Implementation: Vaccination programs necessitate investments in vaccines, equipment, and trained workers. This is a financial strain for some poultry farmers, especially those operating on a small scale. Also, executing efficient immunization programs on big chicken farms necessitates careful planning, logistics, and biosecurity precautions. Developing cost-effective vaccination options, providing farmers with training and technical support, and streamlining vaccination procedures all contribute to overcoming these difficulties and increasing vaccination practice uptake.

Key Trends:

Development of Recombinant Vaccines and Vector Vaccines: Traditional poultry vaccines use inactivated pathogens, while recombinant vaccines use particular genes to trigger an immune response, and vector vaccines use harmless viruses to deliver protective antigens. These modern methods provide broader protection, may improve safety, and increase production efficiency in chicken vaccination.
Focus on In-ovo Vaccination and Automation: In-ovo vaccination involves injecting vaccines into embryonated eggs, resulting in earlier chick protection and better immune responses than traditional techniques. Automation, which includes automated vaccination devices and data systems, is intended to streamline procedures, minimize labor costs, and assure exact and consistent immunization throughout poultry farms.
Rise of Multimodal Vaccination Programs and Vaccination Monitoring: Multimodal vaccination programs use various vaccines to battle emerging diseases and improve flock health. Farmers may optimize vaccination tactics and enhance overall chicken health management by using advanced monitoring tools to assess vaccination coverage, antibody levels, and disease outbreaks in real-time.

Global Poultry Vaccines Market Regional Analysis

Here is a more detailed regional analysis of the poultry vaccines market:

Asia Pacific:

According to Verified Market Research, the Asia Pacific region is estimated to dominate the poultry vaccines market over the forecast period. The Asia-Pacific region has the world's largest poultry production sector, with China dominating both production and consumption of poultry meat. A flourishing chicken business requires a strong market for poultry vaccinations to protect flock health, improve biosecurity measures, and meet rising demand for safe poultry products.
Governments around the Asia Pacific are becoming more aware of the economic and public health dangers posed by avian illnesses. Poultry farmers have become more conscious of the importance of vaccination programs for disease prevention and management. Government initiatives such as vaccine subsidies and planned vaccination campaigns help to boost market expansion.
Furthermore, many of Asia Pacific's small and medium-sized chicken farms demand low-cost immunization alternatives. Vaccine makers in the region are reacting by developing cost-effective poultry vaccinations customized to local demands. Local production capabilities reduce reliance on imports, providing timely delivery and excellent cold chain management to keep vaccines effective.

North America:

North America is estimated to exhibit substantial growth during the forecast period. North American chicken breeders follow strict biosecurity regulations and disease control procedures. Mandatory vaccination programs for certain chicken diseases are enforced, resulting in extensive vaccine use. The emphasis on biosecurity standards within the industry emphasizes preventive measures such as vaccination to reduce outbreak risks and maintain chicken flock health.
North America leads in animal health research, which drives ongoing innovation in poultry vaccinations. Manufacturers are exploring recombinant vaccines, vector vaccines, and in-ovo immunization technologies to improve efficacy and convenience of delivery. These innovations enhance disease control capacities, hence improving overall poultry health management in the region.
Furthermore, the North American poultry industry is progressively adopting precision livestock farming (PLF) technologies. PLF optimizes production through the use of sensors, analytics, and automation. Immunization programs connected with PLF systems allow for real-time monitoring of immunization status, bird health, and illness identification. This data-driven method improves vaccination effectiveness and disease management on poultry farms in North America.

Europe:

European countries encourage preventative healthcare in animal husbandry, stressing immunization to limit disease transmission and dependency on medications. Stringent laws prohibit the use of antibiotics as growth boosters, emphasizing vaccines as the major strategy for keeping chickens healthy.
European consumers are increasingly concerned with food safety and sustainability. Poultry vaccination programs reduce disease transmission, resulting in safe and reliable poultry products. Vaccination supports sustainable farming techniques by improving animal welfare and minimizing the environmental impact of antibiotic use.
Furthermore, Europe is a leader in animal health research, which drives innovation in poultry vaccines. Advanced vaccines are effective against a wide range of diseases. Strict EU biosecurity laws require excellent cleanliness standards and disease control methods on chicken farms, with vaccination playing an important part in compliance and farm biosecurity.

Global Poultry Vaccines Market: Segmentation Analysis

The Poultry Vaccines Market is segmented based on Product Type, Disease Type, Dosage Form, Application, and Geography.

Poultry Vaccines Market, By Product Type

Modified or Attenuated (Live)
Inactivated (Killed)
Recombinants

Based on the Product Type, the market is segmented into Modified or Attenuated, Inactivated, and Recombinants. The inactivated segment is estimated to dominate the poultry vaccines market due to their safety, acceptability for birds of all ages, and efficacy against a variety of poultry diseases. They benefit from existing production processes, possible cost savings, and regulatory acceptance based on their demonstrated efficacy and safety profile in preventing chicken illnesses.

Poultry Vaccines Market, By Disease Type

Newcastle Disease
Marek's Disease
Infectious Bronchitis
Infectious Bursal Disease
Others

Based on the Disease Type, the market is segmented into Newcastle Disease, Marek's Disease, Infectious Bronchitis, Infectious Bursal Disease, and Others. The Newcastle disease segment is estimated to dominate the poultry vaccines market during the forecast period due to its highly contagious nature and destructive impact on poultry. This avian paramyxovirus causes significant economic losses due to high mortality rates, reduced egg output, and probable trade restrictions. Many countries require ND vaccination to prevent its spread and protect poultry industries, as it is recognized as a concern worldwide. Continuous vaccination efforts against various strains of ND strengthen its market position.

Poultry Vaccines Market, By Dosage Form

Liquid Vaccine
Freeze Dried Vaccine
Duct

Based on the Dosage Form, the market is segmented into Liquid Vaccine, Freeze Dried Vaccine, and Duct. The liquid vaccine segment is estimated to exhibit the highest growth within the poultry vaccines market owing to its ease of administration by drinking water, eye drops, or spray methods. This convenience makes liquid vaccinations ideal for bulk vaccination in large-scale chicken farms. Furthermore, their lower production costs compared to freeze-dried vaccines make them appealing to poultry farmers, particularly in areas with a high concentration of small to medium-sized enterprises. Liquid vaccines are especially well suited for broiler applications, where their rapid immune response matches the demands of shorter production cycles.

Poultry Vaccines Market, By Application

Breeder
Broiler
Layer

Based on Application, the market is segmented into Breeder, Broiler, and Layer. The broiler segment is estimated to dominate the poultry vaccines market. Broiler chickens reared for meat have a limited lifespan and are housed in high densities, which increases disease transmission risks. Vaccination is critical in these situations to avoid epidemics and keep flocks healthy. Given the economic importance of the broiler business and its huge worldwide production volumes, effective vaccination programs are critical to reducing economic losses from disease outbreaks and assuring a steady supply of poultry meat.

Poultry Vaccines Market, By Geography

North America
Europe
Asia Pacific
Rest of the World

Based on Geography, the Poultry Vaccines Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. According to the VMR analyst, Asia Pacific is estimated to dominate during the forecasted period. The Asia Pacific region, led by major chicken producers such as China, is experiencing tremendous growth in the poultry business. This spike emphasizes the need for a strong poultry vaccine market to protect flock health and meet the growing demand for safe chicken products. Governments are actively pushing vaccination programs, financing vaccinations, and encouraging local production to ensure cost-effective solutions and disease control across a wide range of chicken farming environments.

Key Players

The "Poultry Vaccines Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Boehringer Ingelheim International GmbH, Zoetis, Inc., Ceva Sante Animale, Merck & Co., Inc., Elanco Animal Health Incorporated, Hester Biosciences Limited, Venkys India Limited, Phibro Animal Health Corporation, Huvepharma AD, and Dechra Pharmaceuticals PLC.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Poultry Vaccines Market Recent Developments
In August 2022, Bimeda, an Ireland-based company specializing in veterinary medications and animal care products, purchased Afrivet for an unknown amount. With this acquisition, Bimeda will have the largest animal health company presence in Africa. Afrivet is a South African manufacturer of chicken vaccinations.
In December 2021, Immuno-intelligent Limited, an Indian antibody maker, introduced a new goat pox vaccine to prevent disease. At 90 days old, a live, weakened antibody should be administered subcutaneously at a rate of 1 ml.